نتایج جستجو برای: i 124

تعداد نتایج: 1052500  

Journal: :PLoS ONE 2007
Luis A. Diaz Catherine A. Foss Katherine Thornton Sridhar Nimmagadda Christopher J. Endres Ovsev Uzuner Thorsten M. Seyler Slif D. Ulrich Janet Conway Chetan Bettegowda Nishant Agrawal Ian Cheong Xiaosong Zhang Paul W. Ladenson Barry N. Vogelstein Michael A. Mont Shibin Zhou Kenneth W. Kinzler Bert Vogelstein Martin G. Pomper

BACKGROUND Traditional imaging techniques for the localization and monitoring of bacterial infections, although reasonably sensitive, suffer from a lack of specificity. This is particularly true for musculoskeletal infections. Bacteria possess a thymidine kinase (TK) whose substrate specificity is distinct from that of the major human TK. The substrate specificity difference has been exploited ...

Journal: :Investigative ophthalmology & visual science 2017
John Byron Christoforidis Karen Briley Katherine Binzel Prayna Bhatia Lai Wei Krishan Kumar Michael Vinzenz Knopp

Purpose To determine the intravitreal pharmacokinetic properties and to study the systemic biodistribution characteristics of I-124-labeled bevacizumab, ranibizumab, and aflibercept with positron emission tomography-computed tomography (PET/CT) imaging in a nonhuman primate model. Methods Three groups with four owl monkeys per group underwent intravitreal injection with 1.25 mg/0.05 mL I-124 ...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2014
Scott M Knowles Kirstin A Zettlitz Richard Tavaré Matthew M Rochefort Felix B Salazar David B Stout Paul J Yazaki Robert E Reiter Anna M Wu

UNLABELLED Prostate stem cell antigen (PSCA) is expressed on the cell surface in 83%-100% of local prostate cancers and 87%-100% of prostate cancer bone metastases. In this study, we sought to develop immunoPET agents using (124)I- and (89)Zr-labeled anti-PSCA A11 minibodies (scFv-CH3 dimer, 80 kDa) and evaluate their use for quantitative immunoPET imaging of prostate cancer. METHODS A11 anti...

2013
Stephen P. Povoski Nathan C. Hall Douglas A. Murrey David S. Sharp Charles L. Hitchcock Cathy M. Mojzisik Eamonn E. Bahnson Michael V. Knopp Edward W. Martin Robert R. Bahnson

Renal cell carcinoma (RCC) accounts for approximately 85% to 90% of all primary kidney malignancies, with clear cell RCC (ccRCC) constituting approximately 70% to 85% of all RCCs. This study describes an innovative multimodal imaging and detection strategy that uses (124)I-labeled chimeric monoclonal antibody G250 ((124)I-cG250) for accurate preoperative and intraoperative localization and conf...

Journal: :American journal of translational research 2016
Xin Gong Huiqing Wang Yongyi Ye Yugao Shu Yongwen Deng Xiaozheng He Guohui Lu Shizhong Zhang

The important roles of miR-124 in the development and progression of various diseases are being increasing recognized. This study was aimed to investigate the potential roles of miR-124 in dopaminergic (DA) neuronal apoptosis and autophagy in Parkinson's disease (PD) and to explore their mechanisms. Human SH-SY5Y cells that are treated with MPTP were transfected with mature miR-124 vector and c...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2013
Derrek A Heuveling Remco de Bree Danielle J Vugts Marc C Huisman Leonardo Giovannoni Otto S Hoekstra C René Leemans Dario Neri Guus A M S van Dongen

UNLABELLED The aim of this microdosing phase 0 clinical study was to obtain initial information about pharmacokinetics, biodistribution, and specific tumor targeting of the antitenascin-C mini antibody F16SIP. METHODS Two milligrams of F16SIP, labeled with 74 MBq of (124)I, were intravenously administered to patients with head and neck cancer (n = 4) scheduled for surgery 5-7 d later. Immuno-...

Journal: :Molecular cancer therapeutics 2010
Ganchimeg Ishdorj James B Johnston Spencer B Gibson

Phosphorylation of STAT3 on serine 727 regulates gene expression and is found to be elevated in many B-leukemia cells including chronic lymphocytic leukemia (CLL). It is, however, unclear whether targeting STAT3 will be an effective antileukemia therapy. In this study, we assessed in vitro antileukemia activity of the STAT3 inhibitor JSI-124 (cucurbitacin I). JSI-124 potently induces apoptosis ...

2016
Fook T. Lee Ingrid J. G. Burvenich Nancy Guo Pece Kocovski Henri Tochon-Danguy Uwe Ackermann Graeme J. O’Keefe Sylvia Gong Angela Rigopoulos Zhanqi Liu Hui K. Gan Andrew M. Scott

PURPOSE The aims of the study were to develop and evaluate a novel residualizing peptide for labeling internalizing antibodies with (124)I to support clinical development using immuno-positron emission tomography (PET). METHODS The anti-epidermal growth factor receptor antibody ch806 was radiolabeled directly or indirectly with isotopes and various residualizing peptides. Azido-derivatized ra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید